Get started
Author

Güldas Köse

Observed names: G Köse, Guldas Köse, GÜLDAS KÖSE
ORCID: 0000-0003-0617-0177
Observed ORCID: 0000-0003-0617-0177
OpenAlex ID: A5024886325
RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults
2025 · Mats C. Højbjerg Lassen, Niklas Dyrby Johansen, et al. · New England Journal of Medicine · 40
Bivalent RSV Prefusion F Protein–Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults
2025 · Mats C. Højbjerg Lassen, Niklas Dyrby Johansen, et al. · JAMA · 31
Associations between cortical thickness and auditory verbal hallucinations in patients with schizophrenia: A systematic review
2018 · Güldas Köse, Kasper Jessen, et al. · Psychiatry Research Neuroimaging · 22
Pathogen distribution and antimicrobial resistance in infections in migrants and nonmigrants in Denmark, a cross‐sectional study
2022 · Rikke Thoft Nielsen, Güldas Köse, et al. · Tropical Medicine & International Health · 10
Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial
2025 · Manan Pareek, Mats C Højbjerg Lassen, et al. · European Heart Journal · 8
PDF
Effect of RSV Vaccine on Heart Failure Hospitalizations
2025 · Kristoffer Grundtvig Skaarup, Mats C. Højbjerg Lassen, et al. · Journal of the American College of Cardiology · 7
PDF
Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults
2026 · Mats C. H. Lassen, Sine H. Christensen, et al. · NEJM Evidence · 2
Effect of RSV vaccine in older adults with atrial fibrillation: a prespecified analysis of the DAN-RSV trial
2026 · Caroline Espersen, Mats C H Lassen, et al. · European Journal of Preventive Cardiology · 2
Durability of RSV Prefusion F Vaccine Protection across Two RSV Seasons
2026 · Mats C. H. Lassen, Niklas Dyrby Johansen, et al. · NEJM Evidence · 1
Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trial
2026 · Lisa Steen Duus, Mats C H Lassen, et al. · European Journal of Preventive Cardiology · 1
Remote Patient Care of Patients with Heart Failure: A Focused Review on the HeartLogic-System
2026 · TAREK BEKFANI, JAKOB ØYSTEIN SIMONSEN, et al. · Journal of Cardiac Failure · 1
Effect of Colchicine on Arterial Stiffness in Patients With Hypertension: The COlchicine HypERtENsion Trial (COHERENT)
2026 · Adam Femerling Langhoff, Niklas Dyrby Johansen, et al. · European Journal of Preventive Cardiology
Effect of RSVpreF Vaccination According to Cardio-Kidney-Metabolic Overlap in Older Adults: A DAN-RSV Trial Analysis
2026 · Mats C H Lassen, Niklas Dyrby Johansen, et al. · European Journal of Preventive Cardiology
RSV prefusion F vaccine effectiveness in older adults with immunosuppression: a prespecified analysis of the DAN-RSV trial
2026 · Anne Marie Reimer Jensen, Mats C Højbjerg Lassen, et al. · The Lancet Healthy Longevity
RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial
2026 · Kristoffer Grundtvig Skaarup, Mats C H Lassen, et al. · European Journal of Heart Failure
Risk of Myocarditis and Pericarditis With Bivalent RSV Prefusion F Protein-Based Vaccine
2026 · Marat Yafasov, Mats C. Højbjerg Lassen, et al. · Journal of the American College of Cardiology
Effectiveness of Bivalent RSV Prefusion F Protein–Based Vaccine in Individuals With and Without Atrial Fibrillation
2026 · Caroline Espersen, Mats C. Højbjerg Lassen, et al. · Journal of the American College of Cardiology
A71-10 Bivalent RSV Prefusion F Vaccine for Preventing RSV-Related and All-Cause Respiratory Hospitalizations According to Chronic Lung Disease Status: A Pre-Specified Analysis of the DAN-RSV Trial
2026 · L S Duus, M C H Lassen, et al. · American Journal of Respiratory and Critical Care Medicine
Bivalent RSV Prefusion F Protein–Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial
2026 · Manan Pareek, Mats C. Højbjerg Lassen, et al. · Diabetes Care
PDF
Bivalent RSV Prefusion F Protein-based Vaccine Effectiveness in Persons With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial
2026 · Manan Pareek, Mats C. Højbjerg Lassen, et al.
Bivalent RSV Prefusion F Protein-based Vaccine Effectiveness in Persons With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial
2026 · Manan Pareek, Mats C. Højbjerg Lassen, et al.
224. Immunosuppression and RSV Prefusion F Protein Vaccine Effectiveness in Older Adults: A Prespecified Subanalysis from the DAN-RSV Trial
2026 · Anne Marie Reimer Jensen, Mats C H Lassen, et al. · Open Forum Infectious Diseases
Works count: 20
Citation count: 125
H-index: 6
I10-index: 4
Year
Topic
Type